We’re producing vastly more information than any of us can possibly consume—artificial intelligence may be the key to effectively making use of that data.

The political circus may have been in town in D.C. this week with a host of contentious hearings for a series of President Trump’s Cabinet nominees, but it was also down in Florida where Trump was hosting a GOP retreat at his Doral golf course.

The LinkedIn co-founder is starting Manas AI with “The Emperor of All Maladies” author Siddhartha Mukherjee.

Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is expected to generate between $60 billion and $110 billion annually in value for the pharmaceutical and medical-product industries, according to a McKinsey report released last year.

LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto, California, in the shadow of Stanford University, where he and fellow technology luminary Peter Thiel became friends as college students during the 1980s.

Manas AI Inc., a startup using artificial intelligence to discover new medicines, launched today with $24.6 million in initial funding. The investment was led by General Catalyst and Manas AI co-founder Reid Hoffman. Greylock Partners, where Hoffman was a general partner until 2023, participated as well.

LinkedIn (MSFT) co-founder and venture capitalist Reid Hoffman on Monday launched an AI startup aimed at discovering new treatments for cancer.